首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives.
【24h】

Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives.

机译:一些新型的2-取代的苯并咪唑衍生物的合成及抗癌活性。

获取原文
获取原文并翻译 | 示例
           

摘要

In an effort to establish new candidates with improved anticancer activity, we report here the synthesis of various series of 2-substituted benzimidazoles: 2-[(4-oxothiazolidin-2-ylidene) methyl and (4-amino-2-thioxothiazol-5-yl) benzimidazoles (2 and 3, respectively); 2-[(4-fluorobenzylidene and cycloalkylidene) cyanomethyl] benzimidazoles (4 and 5, respectively), together with the synthesis of certain of 2-[(4- or 5-oxothiazolidin-2-ylidene, 4-substituted thiazolyl-2-ylidene and [1,3]thiazin-2-ylidene)cyanomethyl]benzimidazoles (6, 8, 7 and 9, respectively). Several of the synthesized products were subjected to in vitro anticancer screening that revealed that all the tested compounds exhibited antitumor activity against human hepatocellular carcinoma (HEPG2), human breast adenocarcinoma (MCF7) and human colon carcinoma (HCT 116) cell lines, with IC50's<10 microg/ml.
机译:为了努力建立具有改善的抗癌活性的新候选药物,我们在这里报告了各种系列的2取代的苯并咪唑的合成:2-[((4-氧噻唑烷丁-2-亚基)甲基]和(4-氨基-2-硫代噻唑-5 -yl)苯并咪唑(分别为2和3); 2-[((4-氟亚苄基和环亚烷基)氰基甲基]苯并咪唑(分别为4和5),以及某些2-[(4-或5-氧噻唑烷-2-亚甲基,4-取代的噻唑基-2-亚烷基和[1,3]噻嗪-2-亚甲基)氰甲基]苯并咪唑(分别为6、8、7和9)。对几种合成产物进行了体外抗癌筛选,结果表明,所有测试化合物均对人肝细胞癌(HEPG2),人乳腺腺癌(MCF7)和人结肠癌(HCT 116)细胞系表现出抗肿瘤活性,IC50值< 10微克/毫升。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号